Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features

To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Microbiol
Autors principals:	Fonjungo, Peter N., Mpoudi, Eitel N., Torimiro, Judith N., Alemnji, George A., Eno, Laura T., Lyonga, Esther J., Nkengasong, John N., Lal, Renu B., Rayfield, Mark, Kalish, Marcia L., Folks, Thomas M., Pieniazek, Danuta
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2002
Matèries:	Virology
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120267/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11880402/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.3.837-845.2002
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!